Menu

Theranos Restructuring with Research Focus

The blood-testing company is shutting down clinical labs, laying off more than 300 employees across three states.

Oct 6, 2016
Tracy Vence

FLICKR, STEVE JURVETSON

Theranos is laying off around 340 employees of clinical labs and “wellness centers” in Arizona, California, and Pennsylvania, Chief Executive Officer Elizabeth Holmes announced yesterday (October 5). This year alone, the company has been investigated by various federal agencies for allegedly misleading officials and operating a lab under substandard conditions; Holmes has been banned from running labs for two years.

In an open letter addressed to the firm’s stakeholders, Holmes yesterday said Theranos would be shifting its focus to research only.

“We will return our undivided attention to our miniLab platform,” Holmes wrote, referring to technology she debuted at the American Association for Clinical Chemistry’s annual meeting in Philadelphia this August. “Our ultimate goal is to commercialize miniaturized, automated laboratories capable of small-volume sample testing, with an emphasis on vulnerable patient populations, including oncology, pediatrics, and intensive care.”

As STAT News reported, “Wednesday’s announcement marks perhaps the most significant retreat for a company that had once been valued at $9 billion, higher than any other venture-backed private company in health care. More recently, Forbes had valued it at $0.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!